1384 related articles for article (PubMed ID: 28365312)
1. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
2. In vivo activating transcription factor 3 silencing ameliorates the AMPK compensatory effects for ER stress-mediated β-cell dysfunction during the progression of type-2 diabetes.
Kim JY; Park KJ; Kim GH; Jeong EA; Lee DY; Lee SS; Kim DJ; Roh GS; Song J; Ki SH; Kim WH
Cell Signal; 2013 Dec; 25(12):2348-61. PubMed ID: 23916985
[TBL] [Abstract][Full Text] [Related]
3. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats.
Van der Werf R; Walter C; Bietiger W; Seyfritz E; Mura C; Peronet C; Legrandois J; Werner D; Ennahar S; Digel F; Maillard-Pedracini E; Pinget M; Jeandidier N; Marchioni E; Sigrist S; Dal S
Cardiovasc Diabetol; 2018 Jul; 17(1):104. PubMed ID: 30029691
[TBL] [Abstract][Full Text] [Related]
5. ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.
Kalfon R; Koren L; Aviram S; Schwartz O; Hai T; Aronheim A
Cardiovasc Res; 2017 Feb; 113(2):134-146. PubMed ID: 28082453
[TBL] [Abstract][Full Text] [Related]
6. Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.
Kubota M; Watanabe R; Yamaguchi M; Hosojima M; Saito A; Fujii M; Fujimura S; Kadowaki M
Br J Nutr; 2016 Oct; 116(8):1326-1335. PubMed ID: 27724997
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
8. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
9. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
10. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
11. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
12. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
[TBL] [Abstract][Full Text] [Related]
13. Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose.
Maagensen H; Junker AE; Jørgensen NR; Gluud LL; Knop FK; Vilsbøll T
J Clin Endocrinol Metab; 2018 May; 103(5):2042-2049. PubMed ID: 29506157
[TBL] [Abstract][Full Text] [Related]
14. Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.
Fang J; Ji YX; Zhang P; Cheng L; Chen Y; Chen J; Su Y; Cheng X; Zhang Y; Li T; Zhu X; Zhang XJ; Wei X
Hepatology; 2020 May; 71(5):1592-1608. PubMed ID: 31529495
[TBL] [Abstract][Full Text] [Related]
15. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease.
Rodríguez A; Gena P; Méndez-Giménez L; Rosito A; Valentí V; Rotellar F; Sola I; Moncada R; Silva C; Svelto M; Salvador J; Calamita G; Frühbeck G
Int J Obes (Lond); 2014 Sep; 38(9):1213-20. PubMed ID: 24418844
[TBL] [Abstract][Full Text] [Related]
16. Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes.
Abderrahmani A; Yengo L; Caiazzo R; Canouil M; Cauchi S; Raverdy V; Plaisance V; Pawlowski V; Lobbens S; Maillet J; Rolland L; Boutry R; Queniat G; Kwapich M; Tenenbaum M; Bricambert J; Saussenthaler S; Anthony E; Jha P; Derop J; Sand O; Rabearivelo I; Leloire A; Pigeyre M; Daujat-Chavanieu M; Gerbal-Chaloin S; Dayeh T; Lassailly G; Mathurin P; Staels B; Auwerx J; Schürmann A; Postic C; Schafmayer C; Hampe J; Bonnefond A; Pattou F; Froguel P
Diabetes; 2018 Jul; 67(7):1310-1321. PubMed ID: 29728363
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
Li T; Huang X; Yue Z; Meng L; Hu Y
Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
[TBL] [Abstract][Full Text] [Related]
18. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
19. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
20. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
